Results 31 to 40 of about 243,774 (341)

Icariin prevents oestrogen deficiency–induced alveolar bone loss through promoting osteogenesis via STAT3

open access: yesCell Proliferation, 2020
Alveolar bone osteoporosis has attracted more and more attention because of its profound impact on stomatognathic function and treatment, but current treatments have not been targeted to alveolar bone and might even cause severe side effects.
Hongyuan Xu   +9 more
semanticscholar   +1 more source

Minocycline-loaded PLGA electrospun membrane prevents alveolar bone loss in experimental peridontitis

open access: yesDrug Delivery, 2020
Minocycline (MINO) is a tetracycline antibiotic effective against most of the bacteria microorganisms related to periodontal disease. Additionally, MINO promotes bone in vitro and in vivo.
Yihui Ma   +6 more
semanticscholar   +1 more source

Obesity, Bone Loss, and Periodontitis: The Interlink

open access: yesBiomolecules, 2022
Obesity and periodontitis are both common health concerns that have given rise to considerable economic and societal burden worldwide. There are established negative relationships between bone metabolism and obesity, obesity and diabetes mellitus (DM ...
Pengfei Zhao, Aimin Xu, Wai Keung Leung
doaj   +1 more source

NLRP3 regulates alveolar bone loss in ligature‐induced periodontitis by promoting osteoclastic differentiation

open access: yesCell Proliferation, 2020
NLRP3 inflammasome is a critical part of the innate immune system and plays an important role in a variety of inflammatory diseases. However, the effects of NLRP3 inflammasome on periodontitis have not been fully studied.
Yuyi Chen   +9 more
semanticscholar   +1 more source

Effects of Chronic Ethanol Consumption and Ovariectomy on the Spontaneous Alveolar Bone Loss in Rats

open access: yesInternational Journal of Dentistry, 2020
Postmenopausal estrogen deficiency and ethanol (EtOH) abuse are known risk factors for different diseases including bone tissues. However, little is known about the synergic effects of EtOH abuse and estrogen deficiency on alveolar bone loss in women ...
Priscila Cunha Nascimento   +8 more
doaj   +1 more source

SLIT2 Overexpression in Periodontitis Intensifies Inflammation and Alveolar Bone Loss, Possibly via the Activation of MAPK Pathway

open access: yesFrontiers in Cell and Developmental Biology, 2020
SLIT2, a member of neuronal guidance cues, has been reported to regulate inflammation and cancer progression. Periodontitis is an oral inflammatory disease that degenerates periodontal tissue, alveolar bone and tooth.
Liping Wang   +15 more
semanticscholar   +1 more source

Effect of VEGFC on lymph flow and inflammation‐induced alveolar bone loss

open access: yesJournal of Pathology, 2020
The lymphatic system plays a crucial role in the maintenance of tissue fluid homeostasis and the immunological response to inflammation. The effects of lymphatic drainage dysfunction on periodontitis have not been well studied.
Hua Wang   +11 more
semanticscholar   +1 more source

Preventive Effects of Chlorogenic Acid on Alveolar Bone Loss in Ligature-Induced Periodontitis in Mice

open access: yesApplied Sciences, 2023
Chlorogenic acid (CGA) is a polyphenol that is present in coffee beans, many vegetables, and fruits. Since CGA has been reported to exert antioxidant and anti-inflammatory effects, it is expected to protect against periodontitis. In the present study, we
Yuka Nishida   +9 more
doaj   +1 more source

Salivary Biomarkers Associated with Alveolar Bone Loss [PDF]

open access: yesAnnals of the New York Academy of Sciences, 2007
Abstract:  A longitudinal case–control study was performed to measure the association of salivary biomarkers with alveolar bone loss from a sub‐sample of 1,256 post‐menopausal women enrolled in the Buffalo Women's Health Initiative. From this cohort, 40 subjects with significant alveolar bone loss over a 5‐year period were compared to 40 age‐matched ...
Jean Wactawski-Wende   +5 more
openaire   +3 more sources

A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation

open access: yesBMC Pharmacology and Toxicology, 2020
Background Currently, there are no effective medications to reverse periodontal disease (PD)-induced bone loss. The objective of this study was to test a new anabolic compound, LLP2A-Ale, or with the combination treatment of mesenchymal stromal cell (MSC)
Min Jiang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy